A novel anti-EGFR monoclonal antibody inhibiting tumor cell growth by recognizing different epitopes from cetuximab
- 1 January 2010
- journal article
- Published by Elsevier BV in Journal of Biotechnology
- Vol. 145 (1), 84-91
- https://doi.org/10.1016/j.jbiotec.2009.09.023
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Science and Technology (08A030100610)
- Rural Development Administration (20070401034007)
- National Research Foundation of Korea (KRF-2007-313-D00248)
This publication has 20 references indexed in Scilit:
- Matuzumab Binding to EGFR Prevents the Conformational Rearrangement Required for DimerizationCancer Cell, 2008
- EGFR family: Structure physiology signalling and therapeutic targets†Growth Factors, 2008
- Characterization of a novel anti-human TNF-α murine monoclonal antibody with high binding affinity and neutralizing activityExperimental & Molecular Medicine, 2008
- Comparative Analyses of Complex Formation and Binding Sites between Human Tumor Necrosis Factor-alpha and its Three Antagonists Elucidate their Different Neutralizing MechanismsJournal of Molecular Biology, 2007
- Impact of Single-chain Fv Antibody Fragment Affinity on Nanoparticle Targeting of Epidermal Growth Factor Receptor-expressing Tumor CellsJournal of Molecular Biology, 2007
- Comparing antibody and small-molecule therapies for cancerNature Reviews Cancer, 2006
- Epidermal Growth Factor Receptor Targeting in CancerSeminars in Oncology, 2006
- Structural basis for inhibition of the epidermal growth factor receptor by cetuximabCancer Cell, 2005
- Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complexCancer Cell, 2004
- ErbB Receptors: Directing Key Signaling Networks Throughout LifeAnnual Review of Pharmacology and Toxicology, 2004